{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:44:04Z","timestamp":1789526644870,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003827","name":"NKFIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["K139237"],"award-info":[{"award-number":["K139237"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["RRF-2.3.1-21-2022-00003"],"award-info":[{"award-number":["RRF-2.3.1-21-2022-00003"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["TKP2021-EGA-23"],"award-info":[{"award-number":["TKP2021-EGA-23"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.vph.2023.107208","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T21:41:38Z","timestamp":1691703698000},"page":"107208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Organ-specific model of simulated ischemia\/reperfusion and hyperglycemia based on engineered heart tissue"],"prefix":"10.1016","volume":"152","author":[{"given":"J.","family":"P\u00e1l\u00f3czi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.","family":"Pa\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pigler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rhoden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.V.","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ferdinandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Eschenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"G\u00f6rbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2023.107208_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"Suppl. 2","key":"10.1016\/j.vph.2023.107208_bb0010","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1007\/PL00002934","article-title":"Mortality and causes of death in the WHO multinational study of vascular disease in diabetes","volume":"44","author":"Morrish","year":"2001","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.vph.2023.107208_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"23","key":"10.1016\/j.vph.2023.107208_bb0020","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1056\/NEJMsa053935","article-title":"Explaining the decrease in U.S. deaths from coronary disease, 1980\u20132000","volume":"356","author":"Ford","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.vph.2023.107208_bb0025","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jamacardio.2016.1326","article-title":"Recent trends in cardiovascular mortality in the United States and public health goals","volume":"1","author":"Sidney","year":"2016","journal-title":"JAMA Cardiol."},{"issue":"1","key":"10.1016\/j.vph.2023.107208_bb0030","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1186\/s12889-021-11072-5","article-title":"Recent trends in cardiovascular disease deaths: a state specific perspective","volume":"21","author":"Manemann","year":"2021","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.vph.2023.107208_bb0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s40471-014-0012-6","article-title":"The obesity epidemic: the United States as a cautionary tale for the rest of the world","volume":"1","author":"Imes","year":"2014","journal-title":"Curr. Epidemiol. Rep."},{"issue":"5","key":"10.1016\/j.vph.2023.107208_bb0040","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/01.RES.88.5.513","article-title":"No-flow ischemia inhibits insulin signaling in heart by decreasing intracellular pH","volume":"88","author":"Beauloye","year":"2001","journal-title":"Circ. Res."},{"issue":"2_suppl","key":"10.1016\/j.vph.2023.107208_bb0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/2047487319878371","article-title":"Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications","volume":"26","author":"Dal Canto","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.vph.2023.107208_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13098-017-0225-1","article-title":"Cardiovascular risk assessment in patients with diabetes","volume":"9","author":"Bertoluci","year":"2017","journal-title":"Diabetol. Metab. Syndr."},{"issue":"3","key":"10.1016\/j.vph.2023.107208_bb0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_106_17","article-title":"Risk factors for coronary artery disease: historical perspectives","volume":"18","author":"Hajar","year":"2017","journal-title":"Heart Views"},{"issue":"3","key":"10.1016\/j.vph.2023.107208_bb0060","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2337\/diacare.27.3.704","article-title":"The significant effect of diabetes duration on coronary heart disease mortality: the Framingham heart study","volume":"27","author":"Fox","year":"2004","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.vph.2023.107208_bb0065","doi-asserted-by":"crossref","first-page":"H176","DOI":"10.1152\/ajpheart.00058.2022","article-title":"Guidelines on models of diabetic heart disease","volume":"323","author":"Heather","year":"2022","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"9","key":"10.1016\/j.vph.2023.107208_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12090832","article-title":"Modelling diabetic cardiomyopathy: using human stem cell-derived cardiomyocytes to complement animal models","volume":"12","author":"Purnama","year":"2022","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.vph.2023.107208_bb0075","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s40883-018-0056-0","article-title":"In vitro models of ischemia-reperfusion injury","volume":"4","author":"Chen","year":"2018","journal-title":"Regen. Eng. Transl. Med."},{"issue":"8","key":"10.1016\/j.vph.2023.107208_bb0080","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1096\/fasebj.11.8.9240969","article-title":"Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system","volume":"11","author":"Eschenhagen","year":"1997","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.vph.2023.107208_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009275","article-title":"Engineered heart tissue: a novel tool to study the ischemic changes of the heart in vitro","volume":"5","author":"Katare","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vph.2023.107208_bb0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCRESAHA.109.211458","article-title":"Development of a drug screening platform based on engineered heart tissue","volume":"107","author":"Hansen","year":"2010","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.vph.2023.107208_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/biom10091309","article-title":"Effects of the Delta opioid receptor agonist DADLE in a novel hypoxia-Reoxygenation model on human and rat-engineered heart tissue: a pilot study","volume":"10","author":"Funcke","year":"2020","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.vph.2023.107208_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132186","article-title":"Protection by the NO-donor SNAP and BNP against hypoxia\/Reoxygenation in rat engineered heart tissue","volume":"10","author":"Gorbe","year":"2015","journal-title":"PLoS One"},{"issue":"13\u201314","key":"10.1016\/j.vph.2023.107208_bb0105","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1089\/ten.tea.2010.0617","article-title":"Engineered heart tissue model of diabetic myocardium","volume":"17","author":"Song","year":"2011","journal-title":"Tissue Eng. Part A"},{"issue":"6","key":"10.1016\/j.vph.2023.107208_bb0110","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41401-020-00538-8","article-title":"Engineered cardiac tissues: a novel in vitro model to investigate the pathophysiology of mouse diabetic cardiomyopathy","volume":"42","author":"Wang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.vph.2023.107208_bb0115","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/(SICI)1097-0290(20000405)68:1<106::AID-BIT13>3.0.CO;2-3","article-title":"Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes","volume":"68","author":"Zimmermann","year":"2000","journal-title":"Biotechnol. Bioeng."},{"issue":"4","key":"10.1016\/j.vph.2023.107208_bb0120","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm1394","article-title":"Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts","volume":"12","author":"Zimmermann","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2023.107208_bb0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1475-2840-8-8","article-title":"The signal transduction pathway of PKC\/NF-kappa B\/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats","volume":"8","author":"Min","year":"2009","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.vph.2023.107208_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2020.106678","article-title":"Simulated hyperglycemia impairs insulin signaling in endothelial cells through a hyperosmolar mechanism","volume":"130","author":"Madonna","year":"2020","journal-title":"Vasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.vph.2023.107208_bb0135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yjmcc.2003.10.019","article-title":"Role of connexin 43 in ischemic preconditioning does not involve intercellular communication through gap junctions","volume":"36","author":"Li","year":"2004","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.vph.2023.107208_bb0140","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3389\/fphys.2019.01564","article-title":"A comorbidity model of myocardial ischemia\/reperfusion injury and hypercholesterolemia in rat cardiac myocyte cultures","volume":"10","author":"Makkos","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.vph.2023.107208_bb0145","doi-asserted-by":"crossref","first-page":"4298945","DOI":"10.1155\/2016\/4298945","article-title":"Exogenous nitric oxide protects human embryonic stem cell-derived cardiomyocytes against ischemia\/reperfusion injury","volume":"2016","author":"Paloczi","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.vph.2023.107208_bb0150","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/mus.20931","article-title":"Drug-screening platform based on the contractility of tissue-engineered muscle","volume":"37","author":"Vandenburgh","year":"2008","journal-title":"Muscle Nerve"},{"issue":"24","key":"10.1016\/j.vph.2023.107208_bb0155","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1111\/bph.14059","article-title":"Chronic treatment with novel nanoformulated micelles of rapamycin, Rapatar, protects diabetic heart against ischaemia\/reperfusion injury","volume":"174","author":"Samidurai","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.vph.2023.107208_bb0160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12933-019-0872-7","article-title":"Impact of hyperglycemia on myocardial ischemia-reperfusion susceptibility and ischemic preconditioning in hearts from rats with type 2 diabetes","volume":"18","author":"Kristiansen","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"issue":"23","key":"10.1016\/j.vph.2023.107208_bb0165","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1111\/bph.14993","article-title":"Effect of hyperglycaemia and diabetes on acute myocardial ischaemia-reperfusion injury and cardioprotection by ischaemic conditioning protocols","volume":"177","author":"Penna","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.vph.2023.107208_bb0170","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/pr.113.008300","article-title":"Interaction of risk factors, comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning","volume":"66","author":"Ferdinandy","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.vph.2023.107208_bb0175","first-page":"68","article-title":"Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog","volume":"70","author":"Jennings","year":"1960","journal-title":"Arch. Pathol."},{"issue":"5","key":"10.1016\/j.vph.2023.107208_bb0180","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00395-010-0097-0","article-title":"Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia\/reoxygenation","volume":"105","author":"Gorbe","year":"2010","journal-title":"Basic Res. Cardiol."},{"issue":"2","key":"10.1016\/j.vph.2023.107208_bb0185","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/cvr\/cvp085","article-title":"High glucose sensitizes adult cardiomyocytes to ischaemia\/reperfusion injury through nitrative thioredoxin inactivation","volume":"83","author":"Luan","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2023.107208_bb0190","doi-asserted-by":"crossref","first-page":"9743280","DOI":"10.1155\/2017\/9743280","article-title":"NLRP3 Inflammasome activation-mediated Pyroptosis aggravates myocardial ischemia\/reperfusion injury in diabetic rats","volume":"2017","author":"Qiu","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.vph.2023.107208_bb0195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yexmp.2003.08.003","article-title":"Contradictory effects of short- and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway","volume":"76","author":"Xu","year":"2004","journal-title":"Exp. Mol. Pathol."},{"issue":"6","key":"10.1016\/j.vph.2023.107208_bb0200","first-page":"2534","article-title":"JNK\/PI3K\/Akt signaling pathway is involved in myocardial ischemia\/reperfusion injury in diabetic rats: effects of salvianolic acid a intervention","volume":"8","author":"Chen","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"12","key":"10.1016\/j.vph.2023.107208_bb0205","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.2337\/diabetes.51.12.3461","article-title":"Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes","volume":"51","author":"Pang","year":"2002","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.vph.2023.107208_bb0210","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/apha.12184","article-title":"Detrimental effects of acute hyperglycaemia on the rat heart","volume":"210","author":"Mapanga","year":"2014","journal-title":"Acta Physiol (Oxford)"},{"issue":"6","key":"10.1016\/j.vph.2023.107208_bb0215","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.33549\/physiolres.933362","article-title":"Hyperosmotic environment blunts effectivity of ischemic preconditioning against ischemia-reperfusion injury and improves ischemic tolerance in non-preconditioned isolated rat hearts","volume":"65","author":"Zalesak","year":"2016","journal-title":"Physiol. Res."},{"issue":"11","key":"10.1016\/j.vph.2023.107208_bb0220","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2023.107208_bb0225","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yjmcc.2014.05.009","article-title":"Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation","volume":"74","author":"Hirt","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.vph.2023.107208_bb0230","article-title":"Metformin attenuates cardiac hypertrophy via the HIF-1alpha\/PPAR-gamma signaling pathway in high-fat diet rats","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.vph.2023.107208_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175748","article-title":"Resveratrol inhibits autophagy against myocardial ischemia-reperfusion injury through the DJ-1\/MEKK1\/JNK pathway","volume":"951","author":"Liu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.vph.2023.107208_bb0240","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41419-017-0135-z","article-title":"Cellular death, reactive oxygen species (ROS) and diabetic complications","volume":"9","author":"Volpe","year":"2018","journal-title":"Cell Death Dis."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718912300068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718912300068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:23:39Z","timestamp":1761528219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153718912300068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":48,"alternative-id":["S153718912300068X"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2023.107208","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organ-specific model of simulated ischemia\/reperfusion and hyperglycemia based on engineered heart tissue","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2023.107208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107208"}}